EVALUATION OF THE EFFICACY AND SAFETY OF FLUPIRTINE IN THE THERAPY OF ACUTE NONSPECIFIC LOW BACK PAIN

Download full text PDF
Issue: 
6
Year: 
2017

I. Vyshlova, Candidate of Medical Sciences; Professor S. Karpov, MD; K. Baida, Candidate of Medical Sciences Stavropol State Medical University

Flupirtine is a promising agent for the relief of pain of various origin. It has analgesic, muscle relaxant, and neuroprotective activities. The pharmacological properties of flupirtine allow it to be effectively used to treat low back pain, especially in patients with comorbidity. The analgesic activity and tolerability of flupirtine in the therapy of acute nonspecific low back pain in patients with comorbidity.
Keywords: 
neurology
nonspecific low back pain
flupirtine
tolerability
comorbidity

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Danilov A.B., Nikolaeva N.S. Effektivnost' novoj formy flupirtina (Katadolona forte) v lechenii ostroj boli v spine // Manage pain. – 2013; 1: 44–8.
  2. Kamchatnov P.R., Batysheva T.T., Ganzhula P.A. i dr. Primenenie katadolona u bol'nyh so spondilogennoj dorsalgiej // Zhurn. nevrol. i psihiat. – 2006; 106 (11): 46–8.
  3. Karateev A.E. Chto mozhet stat' al'ternativoj nesteroidnym protivovospalitel'nym preparatam dlja kontrolja ostroj skeletno-myshechnoj boli u patsienta, imevshego v anamneze infarkt miokarda i zheludochno-kishechnoe krovotechenie? // Consilium Medicum. (Pril. Nevrologija i revmatologi ja).– 2016; 1: 5–12.
  4. Levin Ja.I., Strygin K.N., Dobrovol'skaja L.E. Katadolon v lechenii boli v spine // Lechenie nervnyh boleznej. – 2005; 6 (3): 12–7.
  5. Erdes Sh., Galushko E., Zotkin E. i dr. Effektivnost' katadolona (flupirtina) u patsientov s boljami v nizhnej chasti spiny // Vrach. – 2007; 5: 56–9.
  6. Brune K., Patrignani P. New insights into the use of currently available non-steroidal anti-inflammatory drugs // J. Pain Res. – 2015; 20 (8): 105–18. DOI: 10.2147/JPR.S75160.
  7. Klawe C., Maschke M. Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound // Exp. Opin. Pharmacother. – 2009; 10 (9): 1495–500.
  8. Mueller-Schwefe G. Flupirtine in acute and chronic pain associated with muscle tenseness: results of a postmarket surveillance study // Fortschr. Med. Orig. – 2003; 121 (1): 11–8.
  9. Murray C., Barber R., Foreman K. et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition // Lancet. – 2015; 386 (10009): 2145–91. DOI: 10.1016/S0140-6736(15)61340-X.
  10. Raffa R., Pergolizzi Jr. J. The evolving understanding of the analgesic mechanism of action of flupirtine // J. Clin. Pharm. Ther. – 2012; 37: 4–6. DOI: 10.1111/j.1365-2710.2010.01233.x
  11. Uberall M., Essner U., Müller-Schwefe G. 2-week efficacy and tolerability of flupirtine MR and diclofenac in patients with acute low/back pain-results of a post-hoc subgroup analysis of patient-level data from four non-interventional studies // MMW Fortschr Med. – 2013; 155 (Suppl. 4): 115–23.